Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

Impact · against what's priced in

VNDA's valuation is driven upward by the FDA approval of Nereus and strong Fanapt growth, which outweigh short-term strategic losses. The company's strong cash position and revenue guidance provide a stable foundation for its 2026 catalyst run.

VNDA+0.60: No priced-in read yet
In context: The FDA approval of Nereus for motion sickness creates a new revenue stream, while Fanapt's strong sales growth and a $293.8M cash position mitigate the impact of a $22.6M Q3 net loss.
Read from the article alone

Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

earnings
biotech
healthcare
pharmaceuticals
VNDA
cash runway
fda approval
revenue guidance

Search tags

Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

What matters in this story

History Says Nvidia Stock Usually Rises in the Fourth Quarter -- It Has in 20 of the Last 27

Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

What matters in this story

History Says Nvidia Stock Usually Rises in the Fourth Quarter -- It Has in 20 of the Last 27

How each ticker is affected

Track these names every morning.

State Street Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into State Street (STT)

ROSEN, LEADING TRIAL ATTORNEYS, Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO

Unicycive Therapeutics, Inc. Class Action Reminder - Robbins LLP Encourages UNCY Investors to Contact the Firm About Their Rights

ASML Q3: These Yellow Flags Don't Scare Me, But The Valuation Does

Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

What matters in this story

Next reads from the same story arc

History Says Nvidia Stock Usually Rises in the Fourth Quarter -- It Has in 20 of the Last 27

Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus

What matters in this story

Next reads from the same story arc

History Says Nvidia Stock Usually Rises in the Fourth Quarter -- It Has in 20 of the Last 27

How each ticker is affected

Track these names every morning.

State Street Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into State Street (STT)

ROSEN, LEADING TRIAL ATTORNEYS, Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO

Unicycive Therapeutics, Inc. Class Action Reminder - Robbins LLP Encourages UNCY Investors to Contact the Firm About Their Rights

ASML Q3: These Yellow Flags Don't Scare Me, But The Valuation Does